SCHEMBL1069867

SCHEMBL1069867

Fc1[c]c(F)cc(-c2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
CRHBP P24387 2/20 0.39
CRHR2 Q13324 2/20 0.39
MAOA P21397 1/20 0.37
KIF11 P52732 1/20 0.37
MAPK1 P28482 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NOTUM Q6P988 1/20 0.36
MMP3 P08254 1/20 0.36
BCL2L1 Q07817 1/20 0.36
ALOX5 P09917 1/20 0.36
BACE1 P56817 1/20 0.35
HTT P42858 2/20 0.33
ABCC4 O15439 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1066310 0.84 ALDH1A1 (0.38) ALDH1A1AKR1C2AKR1C1CRHBPCRHR2
SCHEMBL1065307 0.84 CYP1A2 (0.39) ALDH1A1AKR1C2AKR1C1CRHBPCRHR2
SCHEMBL9060576 0.83
SCHEMBL4928553 0.81 KIF11 (0.42) ALDH1A1AKR1C2AKR1C1CRHBPCRHR2
SCHEMBL4928847 0.80 PDE4B (0.35) ALDH1A1CYP1A2CYP3A4HTTTSHR
SCHEMBL4250574 0.75 ALDH1A1 (0.44) ALDH1A1MAPK1MMP3GAAKDM4E
SCHEMBL19953076 0.75 AHR (0.50) ALDH1A1KIF11CYP1A2HSD17B10NOTUM
SCHEMBL694723 0.73 ALDH1A1 (0.41) ALDH1A1MAOAKIF11TAAR1HSD17B10
SCHEMBL8452262 0.73 ALDH1A1 (0.75) ALDH1A1CRHBPCRHR2MAOAMAPK1
SCHEMBL4332773 0.73 ALDH1A1 (0.75) ALDH1A1CRHBPCRHR2MAOAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332938-B1 Viral inhibitors LEUVEN K U RES & DEV (BE) 2014-10-01 EP claimed
WO-2011006886-A2 AZOLE COMPOUNDS CARRYING A SULFUR SUBSTITUENT XIV BASF SE (DE) 2011-01-20 WO disclosed
US-20080318962-A1 Fungicides Based on Nitrogen-Containing Heterocycles SYNGENTA CROP PROTECTION, INC. (US) 2008-12-25 US disclosed
EP-1771423-A1 FUNGICIDES BASED ON NITROGEN-CONTAINING HETEROCYCLES Syngeta Participations AG (CH) 2007-04-11 EP disclosed
WO-2005123698-A1 FUNGICIDES BASED ON NITROGEN-CONTAINING HETEROCYCLES SYNGENTA PARTICIPATIONS AG (CH) 2005-12-29 WO disclosed
EP-1244617-A1 SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE STIMULATING HORMONE Ortho-McNeil Pharmaceutical, Inc. (US) 2002-10-02 EP disclosed
WO-2001047875-A1 SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE STIMULATING HORMONE ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318962-A1 Fungicides Based on Nitrogen-Containing Heterocycles DDT, CYP4X1, CBR1 ALDH1A1 2559/4885AKR1C2 1076/4885AKR1C1 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.